Efficacy of dupilumab reveals therapeutic target for IgG4-related disease: simultaneous control of inflammation and fibrosis.
作者信息
Yamamoto Motohisa, Yoshikawa Noritada, Tanaka Hirotoshi
机构信息
Division of Rheumatology, Center for Antibody and Vaccine Therapy, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
Department of Rheumatology and Allergy, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
出版信息
Ann Rheum Dis. 2022 Mar;81(3):e50. doi: 10.1136/annrheumdis-2020-217076. Epub 2020 Feb 7.
Abstract
摘要
Zotero 插件